• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Global Health Marketing & Communications
  • Home
  • About
  • Global Insights
  • Contact

Realizing Rare Opportunities

By: ghmc  |  March 6, 2014  | 

 Alexion, Alfa Communications, Annual General Meeting, GLOBALHealthPR, Guess What PR, MediaMedic Communications, Mileage Communications, Paradigma PEL Comunicación, PR Partners, Progeria, Rare disease, Viva! Communications, World Rare Disease Day

How appropriate that GLOBALHealthPR Australia partner VIVA! Communications chose Alexion’s David Kwasha to share his personal and Company views on rare diseases on World Rare Disease Day during our two-day annual general meeting in Sydney, Australia last week.AGM-14-Logo

He challenged our group of leading, independent health-focused public relations firms to do more to advance the cause of rare diseases, and in particular, ultra-rare diseases.

In the U.S., a rare disease affects fewer than 200,000 persons, and an ultra-rare disease, fewer than 6,000.

David seemed happy to know that GLOBALHealthPR has already supported the location and identification of nearly 100 percent more children with Progeria, most definitely an ultra-rare disease in which children age rapidly. To date, about 110 children have been identified living with Progeria, an increase from 50 or so just five years ago. We titled our campaign “Find the other 150” because at the time, about 200 Progeria children were estimated worldwide.

A child with Progeria usually passes away from a heart ailment by age 13. The good news is that our client, the Progeria Research Foundation, initiated clinical trials several years ago, and published results in the past year demonstrating the effectiveness of a Farnesyltransferase inhibitors (FTIs) as a treatment for Progeria.

Alexion’s commitment to rare diseases, David explained, stems from the need for a collaborative approach to tackling rare and ultra-rare diseases. “Considering the majority of ultra-rare diseases are often the most life-threatening diseases seen in medicine, and commonly affect infants, children and young adults, we need much greater collaboration between government, industry and the general public in this exciting era in which science is unlocking breakthroughs,” said Mr. Kwasha.

2-1/2 Really “G’Days” Down Under!

For now, my thanks to the hosts of the AGM in Sydney, Kirsten Bruce, Paul Jans and VIVA! team members Josie Schwarzer, Joni Thomes, Ruby Archis, Mark Henderson and others. My Spectrum colleague, Andrew Bailey, and I appreciated VIVA!’s attention to detail in planning and conducting every aspect of the meeting. The VIVA! team seasoned each of our 2-1/2 days with just the right mix and dose of Aussie native and British colonial history, culture and business perspective. The VIVA! office is located in Mosman, a tidy, historic outcropping of former military base buildings on a hill overlooking Sydney. Well worth a visit to take in the sights and charms of their distinctive setting.

Thank you, VIVA! team. A rare pleasure for all of us to meet as your guests in Australia!AGM-collage-2014-1024x675

Uncommon Health PR Talent

This year’s Sydney meeting marked our 13th consecutive annual meeting of GLOBALHealthPR partners. Looking around our meeting room at my peers, themselves owner/managers at leading PR firms in countries ranging from Singapore to Portugal to India to Argentina, I thought about what a privilege it is to know and work with successful business people like Paola de la Barreda of PR Partners in Mexico, and Kirsten Bruce, of our host firm VIVA!. These health communications strategists are truly at the top of their class. They understand better than anyone else – they’re at the helm of science-driven communications strategies, based on years of experience conducting successful pharma and other health industry PR campaigns in their respective countries. No one knows the Argentine health market better than Eugenia de la Fuente and her business partner at Paradigma PEL Communications Laura Torres. My friend and former boss from Hill and Knowlton and InterScience, Dr. Ken Rabin, now represents Poland-based Alfa Communications, making his home in Warsaw. Jorge Azevedo of Portugal partner Guess What was also in the house, and brought with him the latest news from the Iberian Peninsula and Mozambique, where Guess What opened an office last year. And Dinesh Chindarkar, partner at MediaMedic, is the unofficial but widely undisputed health social/digital media “wonk” in India.

Hearing each of our partners present his or her insights on what works and what doesn’t work in each market reminded me of how truly special our GLOBALHealthPR partnership is.

As I write this blog, I’m somewhere over western Australia, flying to Singapore for three days of client and prospect meetings with our partners in Singapore (who also journeyed to Sydney), Patsy Phay and Yap Boh Tiong, principals of Mileage Communications Group. Mileage’s footprint also includes Vietnam, Malaysia, Thailand, Indonesia, Myanmar and China.

I’ll file an update in a day or two. It’s my first time to Singapore, so stay tuned!

<< PREVIOUS BLOG TITLE
NEXT blog title >>

LET’S RADICALLY IMPROVE HEALTH OUTCOMES FOR ALL.

CONNECT WITH US >>

© Copyright 2025 Global Health
Marketing & Communications

Privacy & Cookies
This website uses cookies to ensure you get the best experience on our website.
Learn MoreACCEPT >>
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT